COVID-19后胆管病变的内镜特征及ERCP在其管理中的作用
该观察性研究纳入46例确诊COVID-19后胆管病变患者,基于141次ERCP操作的内镜特征,将其归类为危重症继发性硬化性胆管炎的一种变异型,特征为肝内胆管向心性破坏、胆管消失、无肝外受累及胆管内铸型(85%患者),预后差,1年无肝移植生存率44%,内镜下取铸型对胆汁淤积指标有积极影响。
要点
- COVID-19后胆管病变可归类为危重症继发性硬化性胆管炎的变异型,以破坏性为主而非狭窄性。
- 典型胆管造影特征包括肝内胆管向心性破坏、胆管消失、无肝外受累及胆管内铸型(85%患者)。
- 内镜下取铸型对胆汁淤积指标有积极影响,约60%的个别数值下降。
核心结论
- 胃肠道内镜对COVID-19后胆管病变的管理有重要贡献,ERCP不仅具有诊断和预后价值,还具有治疗价值,因此仍不可或缺。
研究设计与样本
- 观察性研究,纳入46例确诊COVID-19后胆管病变患者,基于141次ERCP操作观察内镜特征。
主要发现
- COVID-19后胆管病变在重症监护治疗早期出现,胆汁淤积中位在插管后4.5天发生。
- 该胆管病变以破坏性为主而非狭窄性,造成胆管不可逆损伤。
- 胆管造影典型特征为肝内胆管向心性破坏、胆管消失现象、无肝外受累及胆管内铸型(85%患者)。
- 该胆管病变常并发小胆管周围肝脓肿,胆汁培养分离出屎肠球菌(Enterococcus faecium)和念珠菌属(Candida spp.)。
- 预后差,1年无肝移植生存率为44%;多变量分析显示重症监护病房第25-36天胆红素水平与无肝移植生存负相关(风险比1.08,P<0.001)。
关键数值与推荐
- 胆管内铸型见于85%的患者。
- 1年无肝移植生存率为44%。
- 重症监护病房第25-36天胆红素水平与无肝移植生存负相关的风险比1.08(P<0.001)。
- 内镜介入取铸型后,约60%的胆汁淤积指标(γ-谷氨酰转肽酶、碱性磷酸酶和胆红素)个别数值下降。
临床怎么用
- 胃肠道内镜对COVID-19后胆管病变的管理有重要贡献,ERCP具有诊断、预后和治疗价值,因此仍不可或缺。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Despite growing awareness of post-coronavirus disease 2019 (COVID-19) cholangiopathy as one of the most serious long-term gastrointestinal consequences of COVID-19, the endoscopic features of this disease are still poorly characterized. This study aimed to more precisely define its endoscopic features and to outline the role of endoscopic retrograde cholangiopancreatography (ERCP) in the management of this entity. METHODS: In this observational study, 46 patients with confirmed post-COVID-19 cholangiopathy were included. RESULTS: Based on the endoscopic features observed in 141 ERCP procedures, post-COVID-19 cholangiopathy can be classified as a variant of secondary sclerosing cholangitis in critically ill patients. It appeared early in the course of intensive care treatment of patients with COVID-19 (cholestasis onset 4.5 days after intubation, median). This form of cholangiopathy was more destructive than stricturing in nature and caused irreversible damage to the bile ducts. A centripetal pattern of intrahepatic bile duct destruction, the phenomenon of vanishing bile ducts, the absence of extrahepatic involvement, and the presence of intraductal biliary casts (85% of patients) were typical cholangiographic features of post-COVID-19 cholangiopathy. This cholangiopathy was often complicated by small peribiliary liver abscesses with isolation of Enterococcus faecium and Candida spp. in bile culture. The prognosis was dismal, with a 1-year liver transplantation-free survival rate of 44%. In particular, patients with peribiliary liver abscesses or destruction of the central bile ducts tended to have a poor prognosis (n.s.). As shown by multivariate analysis, bilirubin levels (on intensive care unit day 25-36) negatively correlated with liver transplantation-free survival (hazard ratio 1.08, P < 0.001). Interventional endoscopy with cast removal had a positive effect on cholestasis parameters (gamma-glutamyl transpeptidase, alkaline phosphatase, and bilirubin); approximately 60% of all individual values decreased. DISCUSSION: Gastrointestinal endoscopy makes an important contribution to the management of post-COVID-19 cholangiopathy. ERCP is not only of great diagnostic and prognostic value but also has therapeutic value and therefore remains indispensable.
引用
- Leonhardt S, Grajecki D, Geisel D, et al. Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP. Am J Gastroenterol. 2023. PMID: 37843039. doi:10.14309/ajg.0000000000002562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。